Abstract:Objective We aimed to develop and validate an effective prediction model for hypertensive disorder of pregnancy (HDP) in twin pregnancies after 28 weeks of gestation. Design Retrospective cohort study. Setting Maternity hospital. Participants We recruited twin pregnancies who delivered in Fujian Maternity and Child Health Hospital from January 2014 to December 2019 as a training cohort. Besides, we included twin pregnancies delivered at Fujian Maternity and Child Health Hospital; Women and Children's Hospital of Xiamen University from January 2020 to December 2021 as temporal validation set and geographical validation set, respectively. Main outcome measures We performed univariate analysis, the least absolute shrinkage and selection operator regression and Boruta algorithm to screen variables. Then, we used multivariate logistic regression to construct a nomogram that predicted the risk of HDP in twin pregnancies. We employed the bootstrap resampling method for internal validation, used the receiver operating characteristic (ROC) curve to evaluate the predictive performance of the model and constructed decision curve analysis to assess the clinical benefit of the model. Thereafter validated the nomogram through the index of concordance (C-index) and calibration curves in the temporal validation set and geographical validation set. Results Multivariate logistic regression showed that primipara (OR=1.284, 95% CI=1.016 to 1.622), the higher pre-pregnancy body mass index (OR=1.077, 95% CI=1.039 to 1.116), the higher uric acid (OR=1.004, 95% CI=1.002 to 1.005), the higher urea nitrogen (OR=1.198, 95% CI=1.087 to 1.321), the higher creatinine (OR=1.011, 95% CI=1.002 to 1.020), the higher lactate dehydrogenase (OR=1.001, 95% CI=1.000 to 1.002), the higher ratio of large platelets (OR=1.034, 95% CI=1.020 to 1.048), the lower albumin (OR=0.887, 95% CI=0.852 to 0.924), the lower calcium (OR=0.148, 95% CI=0.058 to 0.375) are influencing factors of HDP in twin pregnancies. The area under the ROC curve of the prediction model was 0.763. The C-index were 0.842 and 0.746, respectively, on the temporal validation set and geographical validation set. Conclusions The new model for predicting HDP in twin pregnancies constructed by clinical characteristics and laboratory indicators had high clinical application value. It can be used to individually evaluate the occurrence of HDP in twin pregnancies after 28 weeks of gestation.

Development and Validation of a Prediction Model for Hyperuricemia Risk in Hypertensive Patients.

Development and Validation of a Renal Involvement Model for Patients with Hyperuricemia: A Cross-Sectional Study.

Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia

The Development and Validation of a Non-Invasive Prediction Model of Hyperuricemia Based on Modifiable Risk Factors: Baseline Findings of a Health Examination Population Cohort.

A simple prediction model of hyperuricemia for use in a rural setting

Study on risk factor analysis and model prediction of hyperuricemia in different populations

Prediction Model of Random Forest for the Risk of Hyperuricemia in a Chinese Basic Health Checkup Test.

A diagnostic prediction model for hypertension in Han and Yugur population from the China National Health Survey (CNHS)

Incidence and Simple Prediction Model of Hyperuricemia for Urban Han Chinese Adults: A Prospective Cohort Study

Development and Validation of a Model to Predict the Risk of Hypertension Using Anthropometric Indicators in the Chinese Population: a Retrospective Cohort Study

Prediction model for the risk of hyperuricemia within a 5 year follow-up among adults aged 35-74 in Taiwan

Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study

Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China

Construction and validation of coronary heart disease risk prediction model for general hospitals in Tacheng Prefecture, Xinjiang, China

Development, validation and economic evaluation of a machine learning algorithm for predicting the probability of kidney damage in patients with hyperuricaemia: protocol for a retrospective study

Development and Validation of a Nomogram-Based Prognostic Model to Predict High Blood Pressure in Children and Adolescents—Findings From 342,736 Individuals in China

Ensemble machine learning prediction of hyperuricemia based on a prospective health checkup population

Derivation and external validation of prediction model for hypertensive disorders of pregnancy in twin pregnancies: a retrospective cohort study in southeastern China

Diagnostic Model for Predicting Hyperuricemia Based on Alterations of the Gut Microbiome in Individuals with Different Serum Uric Acid Levels

Development and Validation of Prediction Models for Hypertension Risks in Rural Chinese Populations

Development and validation of a model for predicting the risk of cardiovascular events in maintenance hemodialysis patients